One in ten clinics in South Africa — across 22 health districts in six provinces — will start to hand out a twice-a-year anti-HIV jab as early as February. The country’s medicines regulator, Sahpra, ...

In April next year, South Africa plans to start rolling out an anti-HIV jab, taken only twice a year, that could end Aids in the country within 14 to 18 years. But is our public health system equipped ...

Two Indian generic drugmakers — Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot around R692 per person per ...

Ndiviwe Mphothulo started in politics at the age of 12 in Soweto, where he was born with activism in his bloodline. Now, a medical doctor and the president of the Southern African HIV Clinicians ...

The scars left by the April 2022 flash floods aren’t obvious to visitors to this part of Inanda, the township just northwest ...

Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot around R692 per person per year. We break down the ...

Obesity is surging in South Africa. What’s fuelling this epidemic and how does it contribute to diabetes and heart disease, SA’s top killers?

In today’s newsletter, Mia Malan explain why HIV scientists and government are once again pitted against each other. Sign up for our newsletter today. In the leafy office park not far from Charlotte ...

In today’s newsletter, Mia Malan explains how US President Donald Trump ordered USAID-funded HIV organisations in SA to shut down. Sign up for our newsletter today. Pepfar-funded HIV organisations in ...

In today’s newsletter, Mia Malan explains how the twice-yearly HIV prevention jab, lenacapavir, will be rolled out with or without the US. Sign up for our newsletter today. The Global Fund for HIV, TB ...

In today’s newsletter, Mia Malan explains why Gilead Sciences and Sahpra are talking about lenacapavir. Sign up for our newsletter now. Gilead Sciences, the maker of a twice-a-year anti-HIV injection, ...